Amwell recognized with Frost & Sullivan's 2026 United States Technology Innovation Leadership Award

Amwell, a leader in virtual care delivery, has been honored with Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition for its unified Amwell Platform. This recognition underscores Amwell's commitment to transforming virtual care delivery through integrated technology, clinical integration, and intelligent orchestration.

Amwell's platform connects patients, health plan members, clinicians, and partner ecosystems, improving access, efficiency, and outcomes in healthcare. The company's approach is rooted in a strategy focused on connected care, interoperability, and continuous digital innovation, positioning the Amwell Platform as an essential operating layer for next-generation healthcare delivery.

Sagar Mukhekar, an Industry Analyst at Frost & Sullivan, praised Amwell's ability to address healthcare fragmentation. "The combination of reliability, flexibility, and clinically integrated workflows positions the Amwell Platform as a strategic enabler for organizations seeking to reduce fragmentation, improve member engagement with covered programs, expand access to care, and create more connected healthcare experiences," Mukhekar said.

Backed by 20 years of technology-enabled care innovation, Amwell has supported the digital transformation of the Defense Health Agency's Military Health System, serving approximately 9.6 million beneficiaries. The company's commitment to measurable outcomes is evident in a landmark study published in Nature Human Behaviour. This study, funded by the National Institute of Mental Health (NIMH), found that students offered SilverCloud® by Amwell® engaged in mental healthcare at more than double the rate of traditional care, experienced lower rates of mental health disorders, and generated an estimated $1.18 million in avoided costs for the study population.

Dan Zamansky, Chief Product and Technology Officer at Amwell, expressed gratitude for the recognition, stating, "As healthcare becomes more digital, it risks becoming more fragmented. Health plans need more than point solutions. They need enterprise infrastructure, clinical integration, and an open platform that brings partners and programs together. Our vision at Amwell is that technology creates value when it improves access, engagement, quality, and efficiency, and produces measurable clinical and business outcomes. We're honored by this recognition from Frost & Sullivan."

Amwell's platform differentiates itself through intelligent orchestration and navigation, guiding members to appropriate programs while providing clinicians with visibility across care plans. The company also evaluates integrated third-party programs for clinical effectiveness, scalability, and enterprise readiness. Frost & Sullivan's recognition highlights Amwell's strategic approach, execution, and technological innovation, which are driving transformative growth and setting new industry standards.

Each year, Frost & Sullivan presents the Technology Innovation Leadership Recognition to companies that demonstrate outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. Amwell's unified approach to digital care is helping reduce fragmentation, improve access, and support more equitable and sustainable healthcare delivery.